Gatehouse Bio
  • Technology
  • Biology
  • Pipeline
  • News & Publications
  • Our Team
  • Contact Us
Menu
  • Technology
  • Biology
  • Pipeline
  • News & Publications
  • Our Team
  • Contact Us

Category: patents

Small RNA predictors for Alzheimer’s Disease

David W Salzman, Alan P Salzman, Neal C Foster, Nathan S. Ray US Patent App. 17/262,045

Methods for identifying and using small RNA predictors

D Salzman US Patent App. 17/313,191 US Patent 11,028,440 US Patent 10,889,862

Small RNA predictors for Huntington’s Disease

D Salzman US Patent App. 16/630,127

Contact Us

All rights reserved. 

22 Strathmore Rd. Suite 411, Natick, MA 01760            

Thanks for your interest! Please fill out the form below to download a copy of our case study

David Salzman, PhD

As founder and CEO of Gatehouse Bio, David has over 14 years of research expertise and experience in microRNA and sRNA biology. He is the force behind the science and technological development required for identifying sRNA diagnostics, targeted assay design, validation, and subsequent product development. He was previously a postdoctoral fellow at the Yale School of Medicine and a scientist at Biogen, where he gained experience in developing clinical and preclinincal biomarker, PK/PD, and diagnostic platforms. David also served as the CSO of MiraDx, spearheading projects to commercialize germline DNA biomarkers in oncology. He earned his PhD in Molecular Biology and Biochemistry from the University of Connecticut and a BS in Environmental Science from the University of Hartford.


View his publication record here.

If you have any questions or would like to set up a call to talk about a future partnership, we would love to hear from you. Please fill out the form below and one of our members will be in touch.